Arons & Arons, LLC. Announces Investigation on Behalf of Intercept Pharmaceuticals Inc. Investors
September 22 2017 - 4:44PM
Business Wire
The Law Firm of Arons & Arons, LLC. has initiated an
investigation of Intercept Pharmaceuticals Inc. (“Intercept” or the
“Company”) (NASDAQ:ICPT) on behalf of the company’s investors for
possible violations of federal securities law.
Intercept investors who would like to discuss this investigation
and their legal options should contact Arons & Arons, LLC.
(Jeffrey S. Arons, Esq.) at (973) 762-0795, (877) 512-7667 or email
us at info@aronslaw.net. For more information please visit
https://www.aronslaw.net/investigations
According to a report issued by Bloomberg, Intercept
Pharmaceuticals, Inc. dropped to its lowest price since 2013 today
after analysts cut their price targets for the shares. This
occurred following reports of additional patient deaths and a
warning by the U.S. Food and Drug Administration. On Thursday, the
FDA said it has identified 19 deaths of people on the Intercept’s
drug, Ocaliva and that the drug may also be associated with liver
in injury in some patients with mild diseases who are receiving the
correct dose. The company’s stock fell as much as 17 percent on
Friday, after dropping 25 percent the day before. Analysts are now
calling into question the credibility of Intercept’s management
after FDA’s safety announcement raised concerns beyond what was
mentioned in a letter the Company sent to doctors the previous
week.
If you are an investor in Intercept, or have information
pertaining to this investigation, you are encouraged to contact
Arons & Arons, LLC. (Jeffrey Arons, Esq.) at (973) 762-0795,
(877) 512-7667 or email us at info@aronslaw.net. For more
information please visit
https://www.aronslaw.net/investigations
Arons & Arons, LLC. is a family oriented firm, that provides
representation for individuals, including investors who have
been victimized by securities fraud. Our attorneys understand the
financial and emotional trauma that securities fraud can cause, and
we are relentless in our efforts to hold corporate wrongdoers
accountable and obtain compensation for our clients. For over 30
years our attorneys have provided personal, accessible, and
effective legal representation for our clients.
www.aronslaw.net
This press release may be considered Attorney Advertising in
some jurisdictions under applicable laws and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170922005669/en/
Arons & Arons, LLC.Jeffrey Arons,
Esq.973-762-0795877-512-7667info@aronslaw.net
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Apr 2023 to Apr 2024